Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Neoplasms 3Motor Activity 2Smoking Cessation 1Smoking 1Neurocognitive Disorders 1Multiple Endocrine Neoplasia Type 1 1Leukemia 1Hematologic Neoplasms 1Graft vs Host Disease 1Depression 1Cognitive Dysfunction 1Chronic Disease 1Breast Carcinoma In Situ 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Health × Clear all
NCT06058312 2026-04-30

MyPrefMed

Centre Antoine Lacassagne

Phase NA Completed
116 enrolled
Tumor-Agnostic

Neoplasms

NCT03979794 2024-11-14

A Distress Screening and Intervention in Cancer Surgery

Baylor College of Medicine

Phase NA Terminated
16 enrolled
Tumor-Agnostic

Neoplasms

NCT03446092 2022-05-12

Mindfulness for People With Incurable Cancer

Lancaster University

Phase NA Completed
3 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡